کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5622726 | 1579256 | 2014 | 10 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Featured ArticleAβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease Featured ArticleAβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease](/preview/png/5622726.png)
BackgroundHigh β-amyloid (Aβ) is associated with faster memory decline in healthy individuals and adults with mild cognitive impairment (MCI). However, longer prospective studies are required to determine if Aβ-related memory decline continues and whether it is associated with increased rate of disease progression.MethodsHealthy controls (HCs; n = 177) and adults with MCI (n = 48) underwent neuroimaging for Aβ and cognitive assessment at baseline. Cognition was reassessed 18 and 36 months later.ResultsCompared with low-Aβ HCs, high-Aβ HC and MCI groups showed moderate decline in episodic and working memory over 36 months. Those with MCI with low Aβ did not show any cognitive decline. Rates of disease progression were increased in the high-Aβ HC and MCI groups.ConclusionsIn healthy individuals, high Aβ likely indicates that Alzheimer's disease (AD)-related neurodegeneration has begun. Once commenced, the rate of decline in cognitive function remains constant across the preclinical and prodromal stages of AD.
Journal: Alzheimer's & Dementia - Volume 10, Issue 6, November 2014, Pages 743-751.e1